The medical tourism market size is expected to reach USD 101.98 billion by 2030, growing at a CAGR of 16.08% from 2025 to 2030, according to a new report by Grand View Research, Inc. Cardiovascular treatment (coronary artery bypass graft and heart valve transplantation), dental treatment (veneers, implants, and crowns), cosmetic treatment (breast implants and facelifts) and orthopedic treatment (knee & hip reconstruction and spinal surgery), are among the most frequently performed procedures for medical tourists.Market Report Highlights
• Based on treatment, the cosmetic segment held the largest revenue share of 24.13% in 2024. On the other hand, the infertility treatment segment is expected to record the fastest CAGR from 2025 to 2030
• Based on the service provider, the private segment accounted for the largest revenue share of 54.47% in 2024 and is expected to have the fastest growth rate during the forecast period.
• Thailand dominated the market in 2024 with a share of 24.40%. Thailand is a key medical tourism destination and is highly popular among foreign travelers.
• India medical tourism market is developing as a popular medical center for patients. The healthcare system in India combines traditional and modern medical practices, making it unique from other countries.
Get deeper insights, latest developments & key market drivers in the Global Medical Tourism Market
Most elective surgeries, such as cosmetic surgery, certain dental surgeries, fertility treatments, and weight loss surgeries, are not covered by insurance companies in the U.S. Limited availability or lack of insurance coverage drives people to seek procedures in countries such as Thailand, India, and Malaysia. Cosmetic surgeries in most countries are considered elective, and therefore, are not covered under health insurance. This results in interested patients seeking treatment options abroad.
Patients can save treatment costs substantially by traveling to countries where such services are provided at lower costs. For instance, according to the American Society of Plastic Surgeons, a breast augmentation procedure average costs around USD 4,500 to USD 5,000 for an individual in the U.S., compared to around USD 3,000 to USD 4,000 in Malaysia. In addition, the cost of IVF treatment in the U.S. is between USD 12,000 and USD 25,000, whereas in Thailand, it is priced at around USD 6,200 and USD 12,000. This price difference has led to an increase in patient arrivals in Asian countries.
Moreover, the option of combining wellness and medical trips with outstanding clinical facilities and traditional medicine therapies is driving many patients to prefer this option. China has emerged as a key destination for travelers seeking stem cell therapies. Stem cell research is banned in several countries. However, it is legal in China and hence tourists consider China for undergoing it legally. The China market is growing rapidly, owing to a globally expanding middle class, an aging population, and an increasing demand for cosmetic surgery.
List of Key Players in the Medical Tourism Market
• MOHW Hengchun Tourism Hospital
• Apollo Hospitals Enterprise Ltd.
• Bumrungrad International Hospital
• Mount Elizabeth Hospitals
• Raffles Medical Group
• Mission Hospital
• Bangkok Hospital
Looking for Medical Tourism Market Research Report? Get your free sample PDF with key data & latest trends.